gusperimus has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyagi, T; Hayashi, K; Ishigaki, Y; Sato, T; Song, DL | 1 |
| Hayashi, K; Ishigaki, Y; Sato, T; Tong-Lin, S | 1 |
2 other study(ies) available for gusperimus and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Suppression of experimental autoimmune myasthenia gravis with new immunosuppressants: 15-deoxyspergualin and actinobolin.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibody Formation; Benzopyrans; Electric Organ; Female; Guanidines; Immunosuppressive Agents; Microscopy, Immunoelectron; Myasthenia Gravis; Neuromuscular Junction; Pyrans; Rats; Receptors, Cholinergic; Torpedo | 1992 |
Treatment of experimental allergic myasthenia gravis with a new immunosuppressant: 15-deoxyspergualin.
Topics: Animals; Autoantibodies; Guanidines; Immunosuppressive Agents; Myasthenia Gravis; Rats; Receptors, Nicotinic | 1988 |